J&J/Merck Seeking Zocor Switch In UK; Mevacor Still Lead U.S. Candidate

The overall benefit to risk ratio for making Zocor (simvastatin) available without a prescription in the UK is "regarded as favorable," according to a consultation document issued Nov. 17 by the British health agency

More from Europe

More from Geography